Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
resTOR Longevity is a specialized medical clinic focused on geroscience and the practical application of longevity medicine to extend human healthspan. The clinic provides evidence-based protocols centered on the supervised use of mTOR inhibitors, primarily rapamycin (sirolimus), to slow the biological aging process. Their clinical services include personalized metabolic assessments and the prescription of longevity-enhancing agents such as metformin and acarbose. By integrating cutting-edge research with clinical monitoring, resTOR Longevity aims to reduce the risk of age-related chronic diseases and optimize cellular health for its patients. The practice is heavily influenced by the work of leading longevity researchers and emphasizes a data-driven approach to anti-aging interventions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on resTOR Longevity Clinic.